Dr. William H. Quayle, MD

Dr. Quayle practices at Houston Eye Surgery Center in Houston, Texas.

Dr. Quayle's NPI, 1144215336, was assigned on September 14, 2005. Dr. Quayle graduated from University of Missouri School of Medicine in 1973. Dr. Quayle's Texas license number on file is G0799.

Dr. Quayle's primary practice is Houston Eye Surgery Center, at 2855 Gramercy St, Houston, TX 77025 in Harris County. The practice phone is (832) 553-7171.

Dr. Quayle's primary practice is Houston Eye Surgery Center in Houston, Texas. Dmand AI also links Dr. Quayle to 2 medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quayle practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Quayle's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Quayle is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Quayle has a license on file in Texas.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Quayle treats.

CMS data shows 1,896 Medicare services from Dr. Quayle across 14 procedure codes in 2024, for 784 Medicare patients. Medicare paid $133,770 for them.

CMS counts 784 Medicare patients who saw Dr. Quayle in 2024. The largest group is 75 to 84, with 347 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Quayle's median patient age at 75, with 61% women.

In 2024, Dr. Quayle wrote 1,593 Medicare Part D claims for 365 patients. 52% of them were for generic drugs. CMS names the drug for 1,518 of them, across 27 drugs with 11 or more claims each, at $146,995 in total drug cost. In 2023, CMS named 1,559 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Quayle for performance year 2024, reported as part of a group. Dr. Quayle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of cataract surgery by Dr. Quayle, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Quayle. The most frequent topics are Iris. Dr. Quayle's most frequent co-author is Marshall Bowes Hamill, MD.

CMS Open Payments shows 109 general payments to Dr. Quayle from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $527.

Dr. Quayle graduated from University of Missouri School of Medicine in 1973.

Dr. Quayle is in network with 21 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.